Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 27, 128 (1 February 2009) | doi:10.1038/nbt0209-128
The bioentrepreneur's road map
Abstract
Bringing regulated biomedical technologies (small molecules, biologics, medical devices, diagnostics and combination products) from the laboratory to the bedside is one of the more complex and resource-intensive journeys an aspiring entrepreneur
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
